Summary of Key Points Core Viewpoint - On January 23, Boyuan Co., Ltd. executed a block trade of 50,000 shares at a transaction price of 87.22 yuan, which represents a discount of 3% compared to the market closing price of 89.92 yuan [1]. Group 1: Transaction Details - The total transaction amount for the block trade was 436.1 thousand yuan, accounting for 1.17% of the total trading volume on that day [1]. - The buyer of the shares was CITIC Securities Co., Ltd., specifically through its Beijing Hujialou branch, while the seller was China Galaxy Securities Co., Ltd., through its Beijing Financial Street branch [2].

证券日报网讯1月21日，博苑股份（301617）在互动平台回答投资者提问时表示，截至2026年1月20日， 公司股东总户数为8985户。 ...

| 权益类证券大宗交易(协议交易) | | | | | | | 团 下载 | | --- | --- | --- | --- | --- | --- | --- | --- | | 交易日期 | 证券代码 | 证券简称 | 成交价格 (元) | 成交量 (万股/万份) | 成交金额 (万元) | 买方营业部 | 卖方营业部 | | 2026-01-21 | 301617 | 博苑股份 | 80.67 | 10.00 | 806.70 中信证券股份有限 | | 中国银河证券股份 | | | | | | | 公司北京呼家楼证 | | 有限公司北京金融 | | | | | | | 共营业邮 | 4-11- 去看 11-4 | | 1月21日，博苑股份大宗交易成交10万股，成交额806.7万元，占当日总成交额的5.69%，成交价80.67 元，较市场收盘价83.17元折价3.01%。 ...

格隆汇1月21日丨博苑股份(301617.SZ)在投资者互动平台表示，公司目前电子级碘化钾已经实现规模化 销售，公司持续关注高纯碘化物在新能源、新材料领域的应用，根据产业发展趋势积极进行新产品研发 和产能布局。 ...

1月20日，博苑股份大宗交易成交15万股，成交额1193.7万元，占当日总成交额的7.96%，成交价79.58 元，较市场收盘价82.04元折价3%。 | 权益类证券大宗交易(协议交易) | | | | | | | 团 下载 | | --- | --- | --- | --- | --- | --- | --- | --- | | 交易日期 | 证券代码 | 证券简称 | 成交价格 | 成交量 | 成交金额 买方营业部 | | 卖方营业部 | | | | | (元) | (万股/万份) | (万元) | | | | 2026-01-20 | 301617 | 博苑股份 | 79.58 | 15.00 | 1,193.70中信证券股份有限 | 中国银河证券股份 | | | | | | | | | 公司北京呼家楼证 有限公司北京金融 | | | | | | | | 劳营业部 | 街证券营业部 | | ...

Core Viewpoint - The stock of Shandong Boyuan Pharmaceutical Chemical Co., Ltd. experienced a decline of 2.10% on January 19, with a trading volume of 160 million yuan, indicating a potential concern regarding investor sentiment and market performance [1]. Financing Summary - On January 19, Boyuan received a financing buy-in amounting to 16.84 million yuan, while the financing repayment was 18.71 million yuan, resulting in a net financing outflow of 1.86 million yuan [1]. - As of January 19, the total financing and securities lending balance for Boyuan was 155 million yuan, with the financing balance accounting for 3.41% of the circulating market value, which is above the 70th percentile of the past year, indicating a relatively high level [1]. - In terms of securities lending, there were no shares repaid or sold on January 19, with the securities lending balance also at zero, placing it in the 90th percentile of the past year, suggesting a high level of inactivity in this area [1]. Company Overview - Boyuan, established on August 6, 2008, is located in Shouguang City, Shandong Province, and specializes in the research, production, and sales of fine chemicals, including organic and inorganic iodides, precious metal catalysts, and luminescent materials [2]. - The company's revenue composition includes iodides (74.56%), specialty functional chemicals (12.79%), trading business (9.94%), and others (2.72%) [2]. - For the period from January to September 2025, Boyuan reported a revenue of 1.073 billion yuan, reflecting a year-on-year growth of 6.60%, while the net profit attributable to shareholders decreased by 22.53% to 132 million yuan [2]. Shareholder Information - As of January 9, 2025, Boyuan had 8,920 shareholders, a decrease of 5.03% from the previous period, with an average of 5,946 circulating shares per person, which is an increase of 5.29% [2]. - The company has distributed a total of 88.41 million yuan in dividends since its A-share listing [3]. - Notable new institutional shareholders include China Aviation New Start Flexible Allocation Mixed A, holding 1.3456 million shares, and Hong Kong Central Clearing Limited, holding 964,400 shares, among others [3].

Group 1 - The stock of Boyuan Co., Ltd. closed down by 2.10% at a price of 85.72 yuan on January 19 [1] - A block trade occurred with a total volume of 50,000 shares and a transaction amount of 4.1575 million yuan, with a transaction price of 83.15 yuan per share, reflecting a premium rate of -3.00% [1] - The buyer was Dongxing Securities Co., Ltd. and the seller was China Galaxy Securities Co., Ltd. [1] Group 2 - Over the past three months, Boyuan Co., Ltd. has recorded three block trades with a total transaction amount of 17.0225 million yuan [1] - In the last five trading days, the stock has declined by 2.15%, with a total net outflow of 10.5584 million yuan from main funds [1]

Core Viewpoint - The company is focusing on the application of iodides in the perovskite field and has initiated technical research and product development in this area, with ongoing projects but no product sales yet [1] Company Overview - The company, Boyuan Co., Ltd. (301617), has a current iodide production capacity of 4,100 tons per year [1] - There is an additional project in the trial production phase with a capacity of 4,000 tons per year [1]

Core Viewpoint - The company is focusing on the application of iodides in the perovskite field and has initiated technical research and product development in this area, with ongoing projects but no product sales yet [1] Group 1 - The company has an existing iodide production capacity of 4,100 tons per year [1] - There is an additional project in the trial production stage with a capacity of 4,000 tons per year [1]

Core Insights - The company has recognized the application of iodides in the perovskite battery sector and is actively conducting technical research and product development in this area [1] Group 1 - The company is currently advancing its research and development projects related to iodides in perovskite batteries [1] - No products have been commercialized or sold yet as the R&D projects are still in progress [1]